Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.

Cognitive decline Parkinson’s disease dementia longitudinal mild cognitive impairment postural instability and gait disorder progression tremor-dominant

Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2022
Historique:
pubmed: 25 1 2022
medline: 14 4 2022
entrez: 24 1 2022
Statut: ppublish

Résumé

Parkinson's disease (PD) is associated with various non-motor symptoms, including cognitive deterioration. Here, we used data from the DEMPARK/LANDSCAPE cohort to describe the association between progression of cognitive profiles and the PD motor phenotypes: postural instability and gait disorder (PIGD), tremor-dominant (TR-D), and not-determined (ND). Demographic, clinical, and neuropsychological six-year longitudinal data of 711 PD-patients were included (age: M = 67.57; 67.4% males). We computed z-transformed composite scores for a priori defined cognitive domains. Analyses were controlled for age, gender, education, and disease duration. To minimize missing data and drop-outs, three-year follow-up data of 442 PD-patients was assessed with regard to the specific role of motor phenotype on cognitive decline using linear mixed modelling (age: M = 66.10; 68.6% males). Our study showed that in the course of the disease motor symptoms increased while MMSE and PANDA remained stable in all subgroups. After three-year follow-up, significant decline of overall cognitive performance for PIGD-patients were present and we found differences for motor phenotypes in attention (β= -0.08, SE = 0.003, p < 0.006) and memory functions showing that PIGD-patients deteriorate per months by -0.006 compared to the ND-group (SE = 0.003, p = 0.046). Furthermore, PIGD-patients experienced more often difficulties in daily living. Over a period of three years, we identified distinct neuropsychological progression patterns with respect to different PD motor phenotypes, with early executive deficits yielding to a more amnestic profile in the later course. Here, in particular PIGD-patients worsened over time compared to TR-D and ND-patients, highlighting the greater risk of dementia for this motor phenotype.

Sections du résumé

BACKGROUND
Parkinson's disease (PD) is associated with various non-motor symptoms, including cognitive deterioration.
OBJECTIVE
Here, we used data from the DEMPARK/LANDSCAPE cohort to describe the association between progression of cognitive profiles and the PD motor phenotypes: postural instability and gait disorder (PIGD), tremor-dominant (TR-D), and not-determined (ND).
METHODS
Demographic, clinical, and neuropsychological six-year longitudinal data of 711 PD-patients were included (age: M = 67.57; 67.4% males). We computed z-transformed composite scores for a priori defined cognitive domains. Analyses were controlled for age, gender, education, and disease duration. To minimize missing data and drop-outs, three-year follow-up data of 442 PD-patients was assessed with regard to the specific role of motor phenotype on cognitive decline using linear mixed modelling (age: M = 66.10; 68.6% males).
RESULTS
Our study showed that in the course of the disease motor symptoms increased while MMSE and PANDA remained stable in all subgroups. After three-year follow-up, significant decline of overall cognitive performance for PIGD-patients were present and we found differences for motor phenotypes in attention (β= -0.08, SE = 0.003, p < 0.006) and memory functions showing that PIGD-patients deteriorate per months by -0.006 compared to the ND-group (SE = 0.003, p = 0.046). Furthermore, PIGD-patients experienced more often difficulties in daily living.
CONCLUSION
Over a period of three years, we identified distinct neuropsychological progression patterns with respect to different PD motor phenotypes, with early executive deficits yielding to a more amnestic profile in the later course. Here, in particular PIGD-patients worsened over time compared to TR-D and ND-patients, highlighting the greater risk of dementia for this motor phenotype.

Identifiants

pubmed: 35068416
pii: JPD212787
doi: 10.3233/JPD-212787
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

905-916

Auteurs

Jennifer Michels (J)

Department of Neurology, RWTH Aachen University Hospital, Aachen, Germany.
JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Hendrik van der Wurp (H)

Department of Geriatric Medicine, University Duisburg-Essen, Germany.

Elke Kalbe (E)

Medical Psychology, Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Sarah Rehberg (S)

Medical Psychology, Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Alexander Storch (A)

Department of Neurology, University Hospital Augsburg, Augsburg, Germany.
Department of Neurology, University of Rostock, and German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.

Katharina Linse (K)

Department of Neurology, University Hospital Augsburg, Augsburg, Germany.

Christine Schneider (C)

Department of Neurology, University Hospital Augsburg, Augsburg, Germany.

Susanne Gräber (S)

German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.

Daniela Berg (D)

German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Department of Neurology, Christian Albrecht University, Kiel, Germany.

Judith Dams (J)

Department of Neurology, Philipps University Marburg, Marburg, Germany.

Monika Balzer-Geldsetzer (M)

Department of Geriatric Medicine, University Duisburg-Essen, Germany.
Department of Neurology, Philipps University Marburg, Marburg, Germany.

Rüdiger Hilker-Roggendorf (R)

Department of Neurology, J.W. Goethe University, Frankfurt/Main, Germany.

Carola Oberschmidt (C)

Department of Neurology, J.W. Goethe University, Frankfurt/Main, Germany.

Simon Baudrexel (S)

Department of Neurology, J.W. Goethe University, Frankfurt/Main, Germany.

Karsten Witt (K)

Department of Neurology, School of Medicine and Health Sciences - European Medical School, University Oldenburg and Research Center Neurosensory Science, Carl von Ossietzky University Oldenburg, Germany.

Nele Schmidt (N)

Department of Neurology, Christian Albrecht University, Kiel, Germany.

Günther Deuschl (G)

Department of Neurology, Christian Albrecht University, Kiel, Germany.

Brit Mollenhauer (B)

Paracelsus-Elena Clinic, Centre of Parkinsonism and Movement Disorders, Kassel, Germany.
Department of Neurology (BM) and Department of Neurosurgery (CT), University Medical Center Goettingen, Goettingen, Germany.

Claudia Trenkwalder (C)

Paracelsus-Elena Clinic, Centre of Parkinsonism and Movement Disorders, Kassel, Germany.
Department of Neurology (BM) and Department of Neurosurgery (CT), University Medical Center Goettingen, Goettingen, Germany.

Inga Liepelt-Scarfone (I)

German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
IB-Hochschule für Gesundheit und Soziales, Stuttgart, Germany.

Annika Spottke (A)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Sandra Roeske (S)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Ullrich Wüllner (U)

Department of Neurology, University Hospital Bonn, and German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Hans-Ulrich Wittchen (HU)

Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany.
Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, München, Germany.

Oliver Riedel (O)

Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.

Jan Kassubek (J)

Department of Neurology, University of Ulm, Ulm, Germany.

Richard Dodel (R)

Department of Geriatric Medicine, University Duisburg-Essen, Germany.
Department of Neurology, Philipps University Marburg, Marburg, Germany.

Jörg Bernhard Schulz (JB)

Department of Neurology, RWTH Aachen University Hospital, Aachen, Germany.
JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Ana Sofia Costa (AS)

Department of Neurology, RWTH Aachen University Hospital, Aachen, Germany.
JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Kathrin Reetz (K)

Department of Neurology, RWTH Aachen University Hospital, Aachen, Germany.
JARA Institute Molecular Neuroscience and Neuroimaging, Forschungszentrum Jülich GmbH and RWTH Aachen University, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH